BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210420
DTEND;VALUE=DATE:20210422
DTSTAMP:20260515T172518
CREATED:20201126T154428Z
LAST-MODIFIED:20201207T142117Z
UID:28066-1618876800-1619049599@www.pharmajournalist.com
SUMMARY:AI Driven Drug Repositioning and Repurposing Summit
DESCRIPTION:The AI Driven Drug Repositioning & Repurposing Summit will bring together 80+ leaders in repurposing and pioneers in AI and machine learning to strategize how repurposing can reach its full potential to: \n\nImprove time and cost savings of drug development\nLeverage the safety advantage in reducing development risk\nUnlock market potential advantage\nImprove return on investment for repurposed drugs\nExplore out-licensing options\n\nThis meeting aims to help pharma\, biotech and academics stay ahead of the curve in their repurposing endeavors during a period exploding with new technologies. Join cutting-edge discussions with the like of AstraZeneca\, BenevolentAI\, and Healx\, to solve ongoing technical challenges surrounding AI tools in repurposing\, understand the delicate risk-reward balance in potential repurposing opportunities and explore lessons learned from AI applications in repurposing during Covid-19. \nFeaturing 2 days of jam-packed content\, this digital summit will provide you with all the information you need to begin implementing AI tools into repurposing projects within your organization. What’s more\, our digital platform allows you to take part in live Q&A with the presenters\, take a tour of the virtual exhibition\, and even join online rooms where you can join targeted interactive discussion groups! \nTo know more about AI Driven Drug Repositioning and Repurposing Summit please click here.
URL:https://www.pharmajournalist.com/event/ai-driven-drug-repositioning-and-repurposing-summit/
LOCATION:Virtual Event
ORGANIZER;CN="Hansonwade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210420
DTEND;VALUE=DATE:20210423
DTSTAMP:20260515T172518
CREATED:20201224T123305Z
LAST-MODIFIED:20201224T123305Z
UID:28380-1618876800-1619135999@www.pharmajournalist.com
SUMMARY:Anti-Infectives Drug Development – Digital Summit
DESCRIPTION:Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater\, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments\, biopharma\, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance. \nWith some now considering the field as the new ‘Wall Street darling’\, especially given the $1 billion launch of the AMR action fund\, the Digital Anti-Infectives Drug Development Summit has arrived as the most comprehensive and industry-dedicated forum that addresses the biggest challenges in the development and commercialization of anti-infective drugs. \n \nBringing together 60+ senior leaders from large pharma\, innovative biotech\, academia and investment companies\, join us this April to discuss data-driven and solution-based approaches that focus on developing high value clinical candidates\, novel modalities and effective strategies\, that address market sustainability and aim for superiority. \nWhat you can expect: \n\nReimagine anti-infective drug development to ensure economic sustainability\, with insight from Merck\, CARB-X & AlloVir\n\n\nExplore the non-traditional approaches employed to combat multi-drug resistance\, with insight from Locus Biosciences\, Peptilogics & SciBac\n\n\nAdvance the clinical superiority of anti-infectives to drive commercial success\, with insight from ContraFect & Summit Therapeutics\n\n\nTarget the unmet medical need to ensure drug development pipeline success\, with insight from BioVersys\, Entasis Therapeutics & Spero Therapeutics\n\n\nDiscover superior novel strategies to combat anti-microbial resistance\, with insight from Techulon\, MicuRX & Princeton University\n\nTo know more about Anti-Infectives Drug Development please click here.
URL:https://www.pharmajournalist.com/event/anti-infectives-drug-development-digital-summit/
LOCATION:Digital Event\, EDT
ORGANIZER;CN="Hansonwade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR